These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18321762)

  • 21. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma.
    Farinati F; Cardin R; Bortolami M; Burra P; Russo FP; Rugge M; Guido M; Sergio A; Naccarato R
    J Viral Hepat; 2007 Dec; 14(12):821-9. PubMed ID: 18070284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus core protein up-regulates anergy-related genes and a new set of genes, which affects T cell homeostasis.
    Domínguez-Villar M; Muñoz-Suano A; Anaya-Baz B; Aguilar S; Novalbos JP; Giron JA; Rodríguez-Iglesias M; Garcia-Cozar F
    J Leukoc Biol; 2007 Nov; 82(5):1301-10. PubMed ID: 17711976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
    Serfaty L; Capeau J
    Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal models in the study of hepatitis C virus-associated liver pathologies.
    Lerat H; Higgs M; Pawlotsky JM
    Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):341-52. PubMed ID: 21651352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus infection can present with metabolic disease by inducing insulin resistance.
    Koike K
    Intervirology; 2006; 49(1-2):51-7. PubMed ID: 16166789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein.
    Moriishi K; Okabayashi T; Nakai K; Moriya K; Koike K; Murata S; Chiba T; Tanaka K; Suzuki R; Suzuki T; Miyamura T; Matsuura Y
    J Virol; 2003 Oct; 77(19):10237-49. PubMed ID: 12970408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular basis for the synergy between alcohol and hepatitis C virus in hepatocarcinogenesis.
    Koike K; Tsutsumi T; Miyoshi H; Shinzawa S; Shintani Y; Fujie H; Yotsuyanagi H; Moriya K
    J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1():S87-91. PubMed ID: 18336672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein.
    Sato S; Fukasawa M; Yamakawa Y; Natsume T; Suzuki T; Shoji I; Aizaki H; Miyamura T; Nishijima M
    J Biochem; 2006 May; 139(5):921-30. PubMed ID: 16751600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of inducible hepatitis C virus transgenic mouse lines.
    Ernst E; Schönig K; Bugert JJ; Bläker H; Pfaff E; Stremmel W; Encke J
    J Med Virol; 2007 Aug; 79(8):1103-12. PubMed ID: 17596832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological alteration and biological properties of hepatocytes not related to tumorigenesis following transfection with HCV core protein.
    Gu J; Wang L; Che Y; Liu L; Jiang L; Dong S; Li W; Li Q
    J Viral Hepat; 2005 Jan; 12(1):20-6. PubMed ID: 15655044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Progression and risk factors for hepatocarcinogenesis in hepatitis C-related cirrhosis--viral factors, host factors, and others].
    Hoshida Y; Kato N; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):596-9. PubMed ID: 15359867
    [No Abstract]   [Full Text] [Related]  

  • 33. [Possible mechanisms of hepatitis C virus-related hepatocarcinogenesis].
    Tanaka N; Aoyama T
    Nihon Rinsho; 2004 Nov; 62(11):2137-44. PubMed ID: 15552900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenesis of hepatitis C virus].
    Moriishi K; Matsuura Y
    Uirusu; 2007 Dec; 57(2):141-9. PubMed ID: 18357752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma.
    Branda M; Wands JR
    Hepatology; 2006 May; 43(5):891-902. PubMed ID: 16628664
    [No Abstract]   [Full Text] [Related]  

  • 36. [HCV-related hepatocellular carcinoma].
    Otsuka M; Kato N; Yoshida H; Yoshida H; Shiratori Y; Omata M
    Uirusu; 2002 Dec; 52(2):295-300. PubMed ID: 12685322
    [No Abstract]   [Full Text] [Related]  

  • 37. The hepatitis C virus alternate reading frame (ARF) and its family of novel products: the alternate reading frame protein/F-protein, the double-frameshift protein, and others.
    Branch AD; Stump DD; Gutierrez JA; Eng F; Walewski JL
    Semin Liver Dis; 2005 Feb; 25(1):105-17. PubMed ID: 15732002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus core protein, lipid droplets and steatosis.
    Roingeard P; Hourioux C
    J Viral Hepat; 2008 Mar; 15(3):157-64. PubMed ID: 18086178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.
    Moriya K; Yotsuyanagi H; Shintani Y; Fujie H; Ishibashi K; Matsuura Y; Miyamura T; Koike K
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1527-31. PubMed ID: 9225025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data.
    Negro F; Sanyal AJ
    Liver Int; 2009 Mar; 29 Suppl 2():26-37. PubMed ID: 19187070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.